Anorexia associated with bronchial cancer;Anorexie au cours du cancer bronchique

Revue des Maladies Respiratoires

Volumn 14, Issue 2, 1997, Pages 113-117

  Jeanfaivre, T ^a   Tuchais, E ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

anorexia; appetite stimulants; bronchial cancer; cachexia; palliative care; weight loss

Indexed keywords

CORTICOSTEROID;

ANOREXIA; HUMAN; LUNG CANCER; PALLIATIVE THERAPY; PSYCHOLOGICAL ASPECT; REVIEW; WEIGHT REDUCTION;

ADRENAL CORTEX HORMONES; ANOREXIA; APPETITE STIMULANTS; CARCINOMA, BRONCHOGENIC; HUMANS; LUNG NEOPLASMS; RISK FACTORS;

EID: 0031011635     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. DEWYS WD, BEGG C, LAVIN PT et al : Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980;69:491-6.
2. DEWYS WD : Anorexia as a general effect of cancer. Cancer 1979;43:2013-9.
3. NELSON KA, WALSH TD, O'DONOVAN PB, SHEEHAN FG, FALK GW : Assessment of upper gastrointestinal motility in the cancer-associated dyspepsia syndrome. J Palliat Care 1993;9:27-31.
4. BERNSTEIN IL, BERNSTEIN ID : Learned food aversions and cancer anorexia. Cancer Treat Rep 1981;65(suppl 1):43-7.
5. REUBEN DB, MOR V, HIRIS J : Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 1988;148:1586-91.
6. CURTIS EB, KRECH R, WALSH TD : Common symptoms in patients with advanced cancer. J Palliat Care 1991;7:28-29.
7. MEDICAL RESEARCH COUNCIL LUNG CANCER WORKING PARTY : Inoperable non-small-cell lung cancer (NSCLC) : a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Br J Cancer 1991; 63:265-70.
8. BLEEHAN NM, GIRLING DJ, MACHIN D, STEPHENS RJ, MEDICAL RESEARCH COUNCIL LUNG CANCER WORKING PARTY : A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fractions in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Br J Cancer 1992;65:934-41.
9. MUERS MF, ROUND CE : Palliation of symptoms in non-small cell lung cancer. A study by the Yorkshire Regional Cancer Organisation Thoracic Group. Thorax 1993;48:339-44.
10. BLEEHAN NM, GIRLING DJ, MACHIN D, STEPHENS RJ, MEDICAL RESEARCH COUNCIL LUNG CANCER WORKING PARTY : A randomised trial of three of six courses of etoposide, cyclophosphamide, methotrexate and vincristine, or six courses of etoposide and ifosfamide in small-cell lung cancer (SCLC). II : Quality of life. Br J Cancer 1993;68: 1157-66.
11. AARONSON NK, AHMEDZAI S, BERGMAN B ET AL FOR THE EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER : QLQ-C30 : a quality of life instrument for use international clinical trials in oncology. JNCI 1933;55: 365-76.
12. KARDINAL CG, LOPRINZI CL, SCHAID DJ et al : A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia. Cancer 1990;65:2657-62.
13. WADLEIGH R, SPAULDING M, LEMBERSKY B, ZIMMER M, SHEPARD K, PLASSE T. Dronabinol enhancement of appetite in cancer patients. Proc Am Soc Clin Oncol 1990;9:1280.
14. NELSON KA, WALSH TD. Metoclopramide in anorexia caused by cancer-associated dyspepsia syndrome (CADS). J Palliat Care 1993;9:14-8.
15. CHLEBOWSKI RT, HEBER D : Hypogonadism in male patients with metastatic cancer prior to chemotherapy. Cancer Res 1982;42:2495-8.
16. CHLEBOWSKI RT, HERROLD J, ALI I et al : Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer. Cancer 1986;58:183-6.
17. GOLD J : Use of hydrazine sulfate in terminal and preterminal cancer patients : results of investigational new drug (IND) study in 84 evaluable patients. Oncology 1975;32: 1-10.
18. LOPRINZI GL, GOLDBERG RG, Su JQ et al: Randomized double-blind, placebo-controlled trial evaluating hydrazine sulfate in patients with newly diagnosed non-small cell lung cancer. Proc Am Soc Clin Oncol 1933;12:337.
19. WOLF J, SPEAR P, YESNER R : Nitrogen mustard and the steroids hormones in the treatment of inoperable bronchogenic carcinoma. Am J Med 1960;29:1008-16.
20. MOERTEL CG, SCHUTT AJ, REITEMEIER RJ : Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer 1974;33:1607-9.
21. WILLOX JC, CORR J, SHAW J, RICHARDSON M, CALMAN KC, DRENNAN M : Prednisolone as an appetite stimulant in patients with cancer. Br Med J 1984;288:27-31.
22. BRUERA E, ROCA E, CEDARO L, CARRARO S, CHACON R : Action of oral methylprednisolone in terminal cancer patients : a prospective randomized double-blind study. Cancer Treat Report 1985;69:751-4.
23. POPIELA T, LUCCHI R, GIONGO F : Methylprednisolone as palliative therapy for female terminal cancer patients. Eur J Cancer Clin Oncol 1989;25:1823-9.
24. LELLI G, ANGELELLI B, GIAMBIASI ME et al : The anabolic effect of high dose medroxyprogesterone acetate in oncology. Pharmacol Res Commun 1983;15:561-8.
25. HORTOBAGYI GN, BUZDAR AU, FRYE D et al : Oral medroxy-progesterone acetate in the treatment of metastatic breast cancer. Breast Cancer Res Treat 1985;5:321-6.
26. IZUO M, YOSHIDA M, TOMINAGA T et al for the JAPANESE GROUP FOR MPA TREATMENT OF BREAST CANCER : A phase III trial of oral high-dose medroxyprogesterone acetate (MPA) in advanced postmenopausal breast cancer. Cancer 1985;56:2576-9
27. NIIRANEN A, KAJANTI M, TAMMILEHTO L, MATTSON K : The clinical effect of medroxyprogesterone (MPA) in elderly patients with lung cancer. Am J Clin Oncol 1990;13:113-6.
28. TCHEKMEDYIAN NS, TAIT N, MOODY M, GRECO FA, AISNER J : Appetite stimulation with megestrol acetate in cachectic cancer patients. Sem Oncol 1986;13:37-43.
29. AISNER J, TCHEKMEDYIAN NS, MOODY M : High-dose megestrol acetate for the treatment of advanced breast cancer. Dose and toxicities. Semin Hematol 1987;24:48-55.
30. LOPRINZI CL, ELLISON NM, SCHAID DJ et al : Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst 1990;82:1127-32.
31. BRUERA E, MACMILLAN K, KUEHN N, HANSON J, MAC DONALD RN : A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and others symptoms in patients with advanced cancer. Cancer 1990; 66:1279-82.
32. TCHEKMEDYIAN NS, HARIRI L, SIAU J : Megestrol acetate in cancer anorexia and weight loss. Proc Am Soc Clin Oncol 1990;9:336.
33. SCHMOLL E, WILKE H, THOLE R, PREUSSER P, WILDFANG I, SCHMOLL HJ : Megestrol acetate in cancer cachexia, Sem Oncol 1991;18:32-4.
34. FELIU J, GONZALEZ-BARON M, BERROCAL A et al : Usefulness of megestrol acetate in cancer cachexia and anorexia. Am J Clin Oncol 1992;15:436-40.
35. HECKMAYR M, GATZEMEIER U : Treatment of cancer weight loss in patients with advanced lung cancer. Oncology 1992;49:32-4.
36. MUSS HB, CASE LD, CATES WILKIE S et al : High-versus standard-dose megestrol acetate in women with advanced breast cancer : a phase III trial of the Piedmont Oncology Association. J Clin Oncol 1990;8:1797-805.
37. LOPRINZI CL, MICHALAK JC, SCHAID DJ et al : Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol 1993;11:762-7.
38. MACBETH FR, GREGOR A, COTTIER B : A randomized study of megestrol acetate (MA) and prednisolone (P) for anorexia and weight loss in patients with lung cancer. Lung Cancer 1994:11(suppl 1):334.